Cargando…
Plasma metabolite profile for primary open-angle glaucoma in three US cohorts and the UK Biobank
Glaucoma is a progressive optic neuropathy and a leading cause of irreversible blindness worldwide. Primary open-angle glaucoma is the most common form, and yet the etiology of this multifactorial disease is poorly understood. We aimed to identify plasma metabolites associated with the risk of devel...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10199010/ https://www.ncbi.nlm.nih.gov/pubmed/37208353 http://dx.doi.org/10.1038/s41467-023-38466-w |
_version_ | 1785044840052948992 |
---|---|
author | Zeleznik, Oana A. Kang, Jae H. Lasky-Su, Jessica Eliassen, A. Heather Frueh, Lisa Clish, Clary B. Rosner, Bernard A. Elze, Tobias Hysi, Pirro Khawaja, Anthony Wiggs, Janey L. Pasquale, Louis R. |
author_facet | Zeleznik, Oana A. Kang, Jae H. Lasky-Su, Jessica Eliassen, A. Heather Frueh, Lisa Clish, Clary B. Rosner, Bernard A. Elze, Tobias Hysi, Pirro Khawaja, Anthony Wiggs, Janey L. Pasquale, Louis R. |
author_sort | Zeleznik, Oana A. |
collection | PubMed |
description | Glaucoma is a progressive optic neuropathy and a leading cause of irreversible blindness worldwide. Primary open-angle glaucoma is the most common form, and yet the etiology of this multifactorial disease is poorly understood. We aimed to identify plasma metabolites associated with the risk of developing POAG in a case-control study (599 cases and 599 matched controls) nested within the Nurses’ Health Studies, and Health Professionals’ Follow-Up Study. Plasma metabolites were measured with LC-MS/MS at the Broad Institute (Cambridge, MA, USA); 369 metabolites from 18 metabolite classes passed quality control analyses. For comparison, in a cross-sectional study in the UK Biobank, 168 metabolites were measured in plasma samples from 2,238 prevalent glaucoma cases and 44,723 controls using NMR spectroscopy (Nightingale, Finland; version 2020). Here we show higher levels of diglycerides and triglycerides are adversely associated with glaucoma in all four cohorts, suggesting that they play an important role in glaucoma pathogenesis. |
format | Online Article Text |
id | pubmed-10199010 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-101990102023-05-21 Plasma metabolite profile for primary open-angle glaucoma in three US cohorts and the UK Biobank Zeleznik, Oana A. Kang, Jae H. Lasky-Su, Jessica Eliassen, A. Heather Frueh, Lisa Clish, Clary B. Rosner, Bernard A. Elze, Tobias Hysi, Pirro Khawaja, Anthony Wiggs, Janey L. Pasquale, Louis R. Nat Commun Article Glaucoma is a progressive optic neuropathy and a leading cause of irreversible blindness worldwide. Primary open-angle glaucoma is the most common form, and yet the etiology of this multifactorial disease is poorly understood. We aimed to identify plasma metabolites associated with the risk of developing POAG in a case-control study (599 cases and 599 matched controls) nested within the Nurses’ Health Studies, and Health Professionals’ Follow-Up Study. Plasma metabolites were measured with LC-MS/MS at the Broad Institute (Cambridge, MA, USA); 369 metabolites from 18 metabolite classes passed quality control analyses. For comparison, in a cross-sectional study in the UK Biobank, 168 metabolites were measured in plasma samples from 2,238 prevalent glaucoma cases and 44,723 controls using NMR spectroscopy (Nightingale, Finland; version 2020). Here we show higher levels of diglycerides and triglycerides are adversely associated with glaucoma in all four cohorts, suggesting that they play an important role in glaucoma pathogenesis. Nature Publishing Group UK 2023-05-19 /pmc/articles/PMC10199010/ /pubmed/37208353 http://dx.doi.org/10.1038/s41467-023-38466-w Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Zeleznik, Oana A. Kang, Jae H. Lasky-Su, Jessica Eliassen, A. Heather Frueh, Lisa Clish, Clary B. Rosner, Bernard A. Elze, Tobias Hysi, Pirro Khawaja, Anthony Wiggs, Janey L. Pasquale, Louis R. Plasma metabolite profile for primary open-angle glaucoma in three US cohorts and the UK Biobank |
title | Plasma metabolite profile for primary open-angle glaucoma in three US cohorts and the UK Biobank |
title_full | Plasma metabolite profile for primary open-angle glaucoma in three US cohorts and the UK Biobank |
title_fullStr | Plasma metabolite profile for primary open-angle glaucoma in three US cohorts and the UK Biobank |
title_full_unstemmed | Plasma metabolite profile for primary open-angle glaucoma in three US cohorts and the UK Biobank |
title_short | Plasma metabolite profile for primary open-angle glaucoma in three US cohorts and the UK Biobank |
title_sort | plasma metabolite profile for primary open-angle glaucoma in three us cohorts and the uk biobank |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10199010/ https://www.ncbi.nlm.nih.gov/pubmed/37208353 http://dx.doi.org/10.1038/s41467-023-38466-w |
work_keys_str_mv | AT zeleznikoanaa plasmametaboliteprofileforprimaryopenangleglaucomainthreeuscohortsandtheukbiobank AT kangjaeh plasmametaboliteprofileforprimaryopenangleglaucomainthreeuscohortsandtheukbiobank AT laskysujessica plasmametaboliteprofileforprimaryopenangleglaucomainthreeuscohortsandtheukbiobank AT eliassenaheather plasmametaboliteprofileforprimaryopenangleglaucomainthreeuscohortsandtheukbiobank AT fruehlisa plasmametaboliteprofileforprimaryopenangleglaucomainthreeuscohortsandtheukbiobank AT clishclaryb plasmametaboliteprofileforprimaryopenangleglaucomainthreeuscohortsandtheukbiobank AT rosnerbernarda plasmametaboliteprofileforprimaryopenangleglaucomainthreeuscohortsandtheukbiobank AT elzetobias plasmametaboliteprofileforprimaryopenangleglaucomainthreeuscohortsandtheukbiobank AT hysipirro plasmametaboliteprofileforprimaryopenangleglaucomainthreeuscohortsandtheukbiobank AT khawajaanthony plasmametaboliteprofileforprimaryopenangleglaucomainthreeuscohortsandtheukbiobank AT wiggsjaneyl plasmametaboliteprofileforprimaryopenangleglaucomainthreeuscohortsandtheukbiobank AT pasqualelouisr plasmametaboliteprofileforprimaryopenangleglaucomainthreeuscohortsandtheukbiobank AT plasmametaboliteprofileforprimaryopenangleglaucomainthreeuscohortsandtheukbiobank |